Further experimental verification is needed to confirm the immunosuppressive role of ITGA2 in the immune regulation of pancreatic cancer microenvironment, as there is a negative correlation between ITGA2 and CD4 and CD8. This evidence concerns the gene CD8A and familial pancreatic carcinoma.